Condition: Locally Advanced Cervical Cancer · Gemcitabine · Chemo-radiotherapy · Sponsor: National Institute of Cancerología
The purpose of this phase III clinical trial, is to evaluate the efficacy and safety of concomitant chemo-radiotherapy with Cisplatin vs Gemcitabine as the first line of treatment in patients with locally advanced cervical cancer, with comorbidities and preserved renal function.
This description comes directly from the study's public registry record.
Lucely C Cetina, MD, MSc · +5215531952791 · lucelycetina.incan@gmail.com
Julissa Luvián, MSc, PhD · +521556934 · juli.luvian.morales@gmail.com
Always discuss trial participation with your own doctor first.
| National Cancer Institute of Mexico | Mexico City, Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06156514